UPC Analytics
ENDE
Analytics175Cases105Decisions57Judges225Parties64Firms

Parties

Filing frequency, side mix, win records, firms typically retained — by corporate group or standalone party.

Regeneron Pharmaceuticals Inc.

Operating company
Clear and return to cohort view
Total cases
10
Claimant-side
4
Respondent-side
6
Win rate
0%
Top opponents
  • Amgen Inc.4
  • Amgen GmbH1
  • Amgen Europe B.V.1
  • Amgen N.V.1
  • Amgen S.R.L.1
Top firms
  • HOFFMANN EITLE PartmbB6
  • Carpmaels & Ransford LLP2
  • CARPMAELS & RANSFORD2
  • BARDEHLE PAGENBERG Partnerschaft mbB2
  • Hoffmann Eitle2
Recent cases
  • 2025-12-23UPC_CFI_2221/2025—Amgen Inc. v Regeneron Pharmaceuticals Inc.
  • 2025-02-28UPC_CFI_195/2025Procedural onlySanofi Biotechnology SAS v Amgen Inc.
  • 2024-09-13UPC_CoA_529/2024RevokedAmgen Inc. v Regeneron Pharmaceuticals Inc.
  • 2024-09-13UPC_CoA_528/2024DismissedAmgen Inc. v Sanofi-Aventis Deutschland GmbH
  • 2024-05-03CC_24999/2024—Amgen S.R.L. v Regeneron Pharmaceuticals Inc.
  • 2023-11-10CC_586764/2023RevokedRegeneron Pharmaceuticals Inc. v Amgen Inc.
  • 2023-09-13UPC_CoA_320/2023Procedural onlySanofi-Aventis Deutschland GmbH v Amgen Inc.
  • 2023-06-26UPC_CFI_14/2023Procedural onlyAmgen Inc. v Sanofi-Aventis Deutschland GmbH
  • —ACT_597355/2023Not infringedSanofi Biotechnologies SAS v Amgen Inc.
  • —ORD_43914/2024Procedural onlyAmgen Inc. v Sanofi-Aventis Deutschland GmbH